ctrl K

Watchlist Price Alert

Fulcrum Therapeutics Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

7.07

-0.31 (-4.20%)

At close: Jun 27, 2025, 2:01 PM

Fulcrum Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	80M	2.81M	6.34M	19.16M	8.82M	n/a	n/a	n/a
Cost of Revenue	1.59M	n/a	2.41M	2.52M	2.38M	2.05M	1.34M	715K
Gross Profit	78.41M	2.81M	3.93M	16.65M	6.44M	-2.05M	-1.34M	-715K
Operating Income	-21.9M	-110.66M	-112.56M	-81.05M	-71.61M	-84.22M	-33.5M	-22.99M
Interest Income	n/a	n/a	n/a	207K	792K	1.51M	n/a	n/a
Pretax Income	-9.72M	-97.33M	-109.87M	-80.85M	-70.82M	-82.68M	-32.59M	-22.96M
Net Income	-9.72M	-97.33M	-105.62M	-78.33M	-68.44M	-79.11M	-32.59M	-22.96M
Selling & General & Admin	36.45M	41.67M	41.69M	30.52M	21.39M	13.14M	8.31M	4.5M
Research & Development	63.39M	71.8M	76.78M	69.7M	59.04M	71.07M	25.18M	18.49M
Other Expenses	2.06M	n/a	2.69M	207K	792K	29K	392K	28K
Operating Expenses	101.9M	113.47M	118.48M	100.22M	80.43M	84.22M	33.5M	22.99M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	101.9M	113.47M	118.48M	100.22M	80.43M	84.22M	33.5M	22.99M
Income Tax Expense	n/a	n/a	-4.25M	-2.52M	-2.38M	-3.56M	910K	-1K
Shares Outstanding (Basic)	61.98M	61.31M	44.99M	35.36M	25.35M	11.05M	16.94M	10.95M
Shares Outstanding (Diluted)	61.98M	61.31M	44.99M	35.36M	25.35M	11.05M	16.94M	10.95M
EPS (Basic)	-0.17	-1.59	-2.35	-2.22	-2.7	-7.16	-1.92	-2.1
EPS (Diluted)	-0.17	-1.59	-2.35	-2.22	-2.7	-7.16	-1.92	-2.1
EBITDA	-18.24M	-108.49M	-109.72M	-78.54M	-69.23M	-82.16M	-32.15M	-22.28M
EBIT	-19.83M	-110.66M	-112.13M	-81.05M	-71.61M	-84.22M	-33.5M	-22.99M
Depreciation & Amortization	1.59M	2.17M	2.41M	2.52M	2.38M	2.05M	1.34M	715K